These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15253274)

  • 21. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM; Welsh J
    Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.
    Liu B; Edgerton S; Yang X; Kim A; Ordonez-Ercan D; Mason T; Alvarez K; McKimmey C; Liu N; Thor A
    Cancer Res; 2005 Feb; 65(3):879-86. PubMed ID: 15705886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas.
    Shibata MA; Ito Y; Morimoto J; Kusakabe K; Yoshinaka R; Otsuki Y
    J Gene Med; 2006 Mar; 8(3):335-52. PubMed ID: 16345101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.
    Chiesa G; Rigamonti E; Lovati MR; Disconzi E; Soldati S; Sacco MG; Catò EM; Patton V; Scanziani E; Vezzoni P; Arnoldi A; Locati D; Sirtori CR
    Mol Nutr Food Res; 2008 Oct; 52(10):1121-9. PubMed ID: 18655005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Gab2 in mammary tumorigenesis and metastasis.
    Ke Y; Wu D; Princen F; Nguyen T; Pang Y; Lesperance J; Muller WJ; Oshima RG; Feng GS
    Oncogene; 2007 Jul; 26(34):4951-60. PubMed ID: 17310989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological features of the Harderian glands in transgenic mice carrying MMTV/N-ras protooncogene.
    Coto-Montes A; Rodríguez-Colunga MJ; Tolivia D; Sánchez-Barceló E
    Microsc Res Tech; 1997 Aug; 38(3):311-4. PubMed ID: 9264342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice.
    Freitas I; Fracchiolla S; Baronzio G; Griffini P; Bertone R; Sitar GM; Barni S; Gerzeli G; Sacco MG
    Anticancer Res; 2003; 23(5A):3783-94. PubMed ID: 14666678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic animals and the study of cancer.
    Murphy D
    Methods Mol Biol; 1993; 18():23-36. PubMed ID: 21390643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model.
    Jeruss JS; Liu NX; Chung Y; Magrane G; Waldman F; Edgerton S; Yang X; Thor AD
    Carcinogenesis; 2003 Apr; 24(4):659-64. PubMed ID: 12727793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling.
    Wakefield LM; Thordarson G; Nieto AI; Shyamala G; Galvez JJ; Anver MR; Cardiff RD
    Comp Med; 2003 Aug; 53(4):424-32. PubMed ID: 14524419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.
    Huang S; Chen Y; Podsypanina K; Li Y
    Neoplasia; 2008 Feb; 10(2):118-24. PubMed ID: 18283333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of glycosaminoglycans in mouse mammary tumors.
    Umbreit JN
    Anticancer Res; 1996; 16(6B):3785-92. PubMed ID: 9042258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of soy isoflavone and endogenous oestrogen on breast cancer in MMTV-erbB2 transgenic mice.
    Zhang GP; Han D; Liu G; Gao SG; Cai XQ; Duan RH; Feng XS
    J Int Med Res; 2012; 40(6):2073-82. PubMed ID: 23321163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice.
    Watson KL; Stalker L; Jones RA; Moorehead RA
    BMC Cancer; 2015 Feb; 15():37. PubMed ID: 25655427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumours of the mammary gland.
    Squartini F; Pingitore R
    IARC Sci Publ; 1994; (111):47-100. PubMed ID: 8082918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.